The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.